Transmedics Group Inc
Change company Symbol lookup
Select an option...
TMDX Transmedics Group Inc
KELYA Kelly Services Inc
NFLX Netflix Inc
LCNB LCNB Corp
ICCH ICC Holdings Inc
DIOD Diodes Inc
CSGP CoStar Group Inc
KDNY Chinook Therapeutics Inc
LE Lands End Inc
AVLR Avalara Inc
Go

Health Care : Health Care Equipment & Supplies | Small Cap Blend
Company profile

Transmedics group, Inc. is a commercial-stage medical technology company. It is focused on developing organ transplant therapy for end-stage organ failure patients across multiple disease states. The Company has designed and developed organ care system (OCS) a portable organ perfusion, optimization and monitoring system that utilizes customized technology to replicate near-physiologic conditions for donor organs outside of the human body. It has developed three OCS products, one for each of lung, heart and liver transplantations. Its OCS clinical programs include OCS Heart EXPAND Trial, OCS Heart EXPAND Continued Access Protocol, or CAP, Trial and OCS Heart PROCEED II Trials. Its organ care system (OCS) technology platform to perfuse donor organs with warm, oxygenated, nutrient-enriched blood, while maintaining the organs in a living, functioning state; the lung is breathing, the heart is beating and the liver is producing bile.

Price
Delayed
$26.82
Day's Change
-0.25 (-0.92%)
Bid
--
Ask
--
B/A Size
--
Day's High
27.50
Day's Low
26.80
Volume
(Light)

Today's volume of 5,243 shares is on pace to be much lighter than TMDX's 10-day average volume of 211,083 shares.

5,243

Display:

Providers:

UpdateCancel
4 providers
July 14, 2021
TransMedics Group's stock is halted in advance of FDA committee meeting

Shares of TransMedics Group Inc. (TMDX) were halted on Wednesday in advance of an advisory committee meeting scheduled for the same day by the Food and Drug Administration. The committee is expected to review the company's premarket approval...(MarketWatch)

Earnings Calendar and Events Data provided by |Terms of Use| © 2021 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2021. All rights reserved.